XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total Precipio, Inc. [Member]
Noncontrolling Interest in Joint Venture [Member]
Total
Balance at beginning of period at Dec. 31, 2019   $ 79 $ 74,065 $ (60,939) $ 13,205   $ 13,205
Balance at beginning of period (in shares) at Dec. 31, 2019 47 7,898,117          
Increase (Decrease) in Stockholders' Equity              
Net (loss) income       (5,454) (5,454) $ 17 (5,437)
Conversion of convertible notes into common stock   $ 39 2,137   2,176   2,176
Conversion of convertible notes into common stock (in shares)   3,908,145          
Issuance of common stock in connection with purchase agreements   $ 28 2,579   2,607   2,607
Issuance of common stock in connection with purchase agreements (in shares)   2,810,654          
Write-off debt premiums (net of debt discounts) in conjunction with convertible note conversions     270   270   270
Write-off beneficial conversion feature in conjunction with convertible note extinguishment     (523)   (523)   (523)
Sock-based compensation     329   329   329
Balance at end of period at Jun. 30, 2020   $ 146 78,857 (66,393) 12,610 17 12,627
Balance at end of period (in shares) at Jun. 30, 2020 47 14,616,916          
Balance at beginning of period at Mar. 31, 2020   $ 95 75,334 (64,144) 11,285   11,285
Balance at beginning of period (in shares) at Mar. 31, 2020 47 9,506,126          
Increase (Decrease) in Stockholders' Equity              
Net (loss) income       (2,249) (2,249) 17 (2,232)
Conversion of convertible notes into common stock   $ 35 1,788   1,823   1,823
Conversion of convertible notes into common stock (in shares)   3,480,148          
Issuance of common stock in connection with purchase agreements   $ 16 1,241   1,257   1,257
Issuance of common stock in connection with purchase agreements (in shares)   1,630,642          
Write-off debt premiums (net of debt discounts) in conjunction with convertible note conversions     333   333   333
Sock-based compensation     161   161   161
Balance at end of period at Jun. 30, 2020   $ 146 78,857 (66,393) 12,610 17 12,627
Balance at end of period (in shares) at Jun. 30, 2020 47 14,616,916          
Balance at beginning of period at Dec. 31, 2020   $ 176 85,523 (71,564) 14,135 27 14,162
Balance at beginning of period (in shares) at Dec. 31, 2020 47 17,576,916          
Increase (Decrease) in Stockholders' Equity              
Net (loss) income       (4,465) (4,465) 4 (4,461)
Issuance of common stock in connection with at the market offering, net of issuance costs   $ 45 14,902   14,947   14,947
Issuance of common stock in connection with at the market offering, net of issuance costs (in shares)   4,501,000          
Issuance of common stock in connection with purchase agreements   $ 5 1,255   1,260   1,260
Issuance of common stock in connection with purchase agreements (in shares)   500,000          
Proceeds upon issuance of common stock from exercise of warrants   $ 1 399   400   400
Proceeds upon issuance of common stock from exercise of warrants (in shares)   74,000          
Issuance of common stock for consulting services   $ 200 150   150   150
Issuance of common stock for consulting services (in shares)   55,147          
Sock-based compensation     800   800   800
Balance at end of period at Jun. 30, 2021   $ 227 103,029 (76,029) 27,227 31 27,258
Balance at end of period (in shares) at Jun. 30, 2021 47 22,707,063          
Balance at beginning of period at Mar. 31, 2021   $ 181 87,365 (73,016) 14,530 28 14,558
Balance at beginning of period (in shares) at Mar. 31, 2021 47 18,132,063          
Increase (Decrease) in Stockholders' Equity              
Net (loss) income       (3,013) (3,013) 3 (3,010)
Issuance of common stock in connection with at the market offering, net of issuance costs   $ 45 14,902   14,947   14,947
Issuance of common stock in connection with at the market offering, net of issuance costs (in shares)   4,501,000          
Proceeds upon issuance of common stock from exercise of warrants   $ 1 399   400   400
Proceeds upon issuance of common stock from exercise of warrants (in shares)   74,000          
Issuance of common stock for consulting services   $ 0          
Issuance of common stock for consulting services (in shares)   0          
Sock-based compensation     363   363   363
Balance at end of period at Jun. 30, 2021   $ 227 $ 103,029 $ (76,029) $ 27,227 $ 31 $ 27,258
Balance at end of period (in shares) at Jun. 30, 2021 47 22,707,063